very low volume, page-5

Here's something positive from the last couple of announcements:

Mar 6 2014 - CPT update:
"The number of FerriScans provided to the US market grew by 33% in the last financial year compared to the previous year and demand continues to grow in the US where FerriScan is the only FDA approved product for the measurement of liver iron concentration. The US market currently represents approximately 20% of the Company’s FerriScan income. Recent growth in FerriScan volumes has been driven by Middle East and Asian countries where the Company has received sizable orders in recent months."

Feb 28 2014 - Half yearly:
"HepaFat-Scan® was cleared for marketing by the FDA on the 19th
December 2013 and the Company is currently investigating a number of commercialisation paths for the test. HepaFat-Scan® is now available to specialist clinicians and pharmaceutical companies developing therapies
to address fatty liver disease using the same service delivery model as FerriScan."

"The Company is also investigating cloud based solutions to enable radiology facilities around the world to use the HepaFat-Scan® product at an affordable price and generate an ongoing income stream, whilst maintaining protection of the IP. "

As bobadah has mentioned before that the company isn't just gonna make news up or sweeten facts to push the SP up for the sake of it. I'd personally rather the company use all their resources on getting results than spending time writing up announcements to push SP along.

Lots to look forward to in the next few months/announcements :)